| Developers: | SiBionics |
| Date of the premiere of the system: | October 2023 |
| Branches: | Pharmaceuticals, Medicine, Healthcare |
2023: Product Announcement
On October 31, 2023, SiBionics announced sales of its GS1 blood sugar monitoring system. She provides doctors and patients with the data they need to maintain control of their blood sugar levels.
GS1 makes it possible to continuously monitor glucose levels for 14 days. SiBionics claim that this is the first blood glucose meter that does not require calibration to work by testing blood from a finger. Data can be transferred to tracking devices or an application in a smartphone. In addition, the application is able to create professional reports and share data with family and friends.
The system is also integrated with the ProView remote access platform, which allows doctors to remotely monitor indicators and take the necessary medical measures on time.
Founded in 2015, SiBionics specializes in combining medical technology and AI. According to November 2023, it employs 700 employees, 40% of whom are engaged in scientific research and development. The GS1 will be used by more than 1,600 hospitals, the company said. The total number of users of the monitoring system should reach 600 thousand people. The company's production capacity is 6 million devices per year.
 | As an innovative medical tech company connecting medical technology and artificial intelligence, SiBionics will try to bring its expertise and new diabetes control technologies to all patients around the world, the company said in a press release.[1] |  |
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |